SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001104659-23-051919
Filing Date
2023-04-28
Accepted
2023-04-28 06:11:54
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-28

Document Format Files

Seq Description Document Type Size
1 ARS tm2313232d1_ars.pdf ARS 3441952
  Complete submission text file 0001104659-23-051919.txt   4737770
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-38650 | Film No.: 23859918
SIC: 2834 Pharmaceutical Preparations